Welcome to our dedicated page for Dassault Systemes news (Ticker: DASTY), a resource for investors and traders seeking the latest updates and insights on Dassault Systemes stock.
Dassault Systèmes SA reports company news centered on its 3DEXPERIENCE platform, virtual twins, and software activity across manufacturing industries, life sciences and healthcare, and infrastructure and cities. Updates commonly cover software revenue, cloud activity, annual run-rate trends, operating cash flow, margin performance, and product themes such as SOLIDWORKS, CENTRIC, 3D UNIV+RSES, and industrial AI.
Company announcements also address shareholder and governance matters, including combined shareholders’ meetings, Universal Registration Document filings with the Autorité des marchés financiers, share repurchase program descriptions, dividend proposals, outstanding share and voting-right declarations, and board leadership changes.
Dassault Systèmes (Ticker: DASTY) reported the total number of outstanding shares and voting rights as of December 31, 2025. The company stated 1,341,806,268 outstanding shares and 2,013,578,477 voting rights.
The release notes that the voting-rights total is calculated on the basis of all outstanding shares, including those whose voting rights are suspended, pursuant to Article 223-11 of the General Regulation of the Autorité des marchés financiers. Shareholders are directed to the investor relations contact for threshold-declaration procedures.
Dassault Systèmes (OTC:DASTY) announced the total number of outstanding shares and voting rights as of November 30, 2025. The company reported 1,341,782,567 outstanding shares and 2,013,594,540 voting rights.
The release notes that voting rights are calculated on the basis of all outstanding shares, including those with suspended voting rights, under Article 223-11 of the Autorité des marchés financiers General Regulation. Shareholders are invited to consult the referenced article for thresholds and to send declarations about threshold crossings to the Investor Relations Service or via Investors@3ds.com.
Dassault Systèmes (DASTY) declared the total number of outstanding shares and voting rights as of October 31, 2025. The company reported 1,341,772,015 outstanding shares and 2,013,588,275 voting rights. The voting-rights total is calculated on the basis of all outstanding shares, including those with suspended voting rights, under Article 223-11 of the AMF General Regulation.
The company reminded shareholders of threshold-declaration rules under Articles 223-16 and 221-3 and provided contact details for the Investor Relations Service for notifications and questions.
Dassault Systèmes (OTC:DASTY) announced that its Medidata brand has extended a 10-plus-year collaboration with Sanofi to support clinical research and speed therapy development. Sanofi will use Medidata Patient, Data, and Study Experiences, including AI-embedded, platform-based solutions and decentralized trial capabilities, with Medidata supplying consulting and end-to-end operational support. The extension aims to unify clinical workflows, reduce silos, and shorten delays to accelerate new therapies and improve patient journeys.
Dassault Systèmes (DASTY) reported a solid Q3 2025 with total revenue up 5% to €1.46B, recurring revenue up 9% and subscription revenue up 16%. 3DEXPERIENCE software revenue rose 16% and 3DEXPERIENCE Cloud grew strongly. Non-IFRS operating margin reached 30.1% (up 100 bps) and non-IFRS diluted EPS was €0.29 (up 10% in constant currency). The group adjusted FY25 revenue growth to 4–6% (from 6–8%) while reaffirming a non-IFRS diluted EPS target of +7–10%. Cash flow and balance-sheet items include €1.33B cash from operations YTD and €3.91B cash and equivalents as of Sept 30, 2025.
Dassault Systèmes (OTC:DASTY) announced on Oct. 23, 2025 an expansion of its 10-plus-year collaboration between Medidata and Sanofi to accelerate clinical research and improve the patient journey.
The new enterprise agreement will deploy Medidata Experiences—patient, data, and study solutions with AI-embedded workflows—to streamline operations, improve data quality, support decentralized clinical trials, and provide strategic consulting and end-to-end operational support to Sanofi.
The expanded partnership aims to reduce silos, cut delays and costs, and speed therapies to market by combining Medidata platform capabilities with Sanofi’s clinical expertise.
Dassault Systèmes (DASTY) declared its total number of outstanding shares and voting rights as of September 30, 2025. The company reported 1,341,653,585 outstanding shares and 2,013,496,529 voting rights.
The total voting rights figure is calculated on the basis of all outstanding shares, including those with suspended voting rights, pursuant to Article 223-11 of the AMF General Regulation. Shareholders are invited to consult the referenced AMF article for threshold declaration rules and to send threshold-crossing declarations to Dassault Systèmes Investor Relations at the provided postal and email addresses.
Dassault Systèmes (DASTY) has disclosed its recent share repurchase activities as part of the program approved by shareholders on May 22, 2025. The company executed two trading sessions on September 8 and 10, 2025, acquiring a total of 30,822 shares.
The transactions were conducted on the XPAR market (Euronext Paris), with 5,822 shares purchased at an average price of €26.7952 on September 8, and 25,000 shares acquired at an average price of €27.6455 on September 10.
Dassault Systèmes (DASTY) has disclosed its recent share repurchase activities from September 2 to September 5, 2025, as part of the buyback program approved by shareholders on May 22, 2025. The company executed significant transactions across different trading venues.
The most notable transaction occurred on September 4, 2025, when the company acquired 4,209,067 shares at €26.57 on DXE. Additional daily purchases on XPAR ranged from 7,452 to 25,000 shares at prices between €26.33 and €26.73 per share.
["Major share repurchase of over 4.2 million shares demonstrates strong commitment to shareholder value", "Consistent daily share repurchases showing systematic execution of buyback program"]Dassault Systèmes (DASTY) has released its monthly share and voting rights declaration as of August 31, 2025. The company reported a total of 1,345,402,716 outstanding shares and 2,017,309,998 voting rights.
This disclosure is made in compliance with French regulatory requirements under articles 223-16 and 221-3 of the General Regulation of the Autorité des marchés financiers (AMF). The voting rights calculation includes all outstanding shares, even those with suspended voting rights.